Smart money activity in the past 24 hours that is out of the ordinary. It includes stock options bought on the ask or sold on the bid with unusual size and daily volume compared to open interest.

Find out more


TG Therapeutics, Inc. is a biopharmaceutical company. It focuses on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company develops two therapies targeting hematological malignancies: TG-1101 and TGR-1202. TG Therapeutics was founded by Michael S. Weiss on May 18, 1993 and is headquartered in New York, NY.

UOA Trade History
Loading...

Bearish Trades

Put trades that are bought on or above the market's asking price OR call trades that are sold on or less than the market's bid price - expecting a move to the downside.



Type Expiration DTE Bid Purchase Price Ask Spread Strike Total Traded Size Volume Trade Condition Timestamp Notes
Put Login To View Login To View Login To View Login To View Login To View Login To View Login To View $23,100 Login To View Login To View 6 days ago Login To View